nnvmnnoh

Property	Value
?:abstract	BACKGROUND: Reports of SARS-CoV2 infection have focused on pregnant women hospitalized due to moderate to severe COVID-19 disease or asymptomatic women diagnosed through universal screening at the time of obstetric admission. Many pregnant women who have symptomatic SARS-CoV2 infection may not meet criteria for hospitalization; however, whether and how these women can be managed safely in outpatient setting is not well described. OBJECTIVE: We sought to describe the time to symptom and viral clearance and to identify predictors of hospitalization in order to better understand the safety of monitoring pregnant patients with symptomatic COVID-19 in the outpatient setting. STUDY DESIGN: We performed a retrospective cohort study of pregnant patients with symptomatic, confirmed COVID-19 illness at a large academic medical center. Patients had systematic telehealth follow up by a clinician team to assess for symptoms, provide virtual prenatal care, and arrange in-person visits when appropriate in a dedicated outpatient center. Data was collected via chart abstraction. RESULTS: Of 180 pregnant patients presenting with symptoms and undergoing RT-PCR testing, 67 patients with confirmed COVID-19 infection were identified during the study period. Nineteen (28%) required acute care given worsening of COVID-19 symptoms, and 95% of these were directed to this acute care setting due to symptom severity telehealth evaluation. Nine women (13%) were admitted to the hospital given worsening symptoms, 3 required ICU care, 2 required ventilatory support, and 2 required delivery. Women with the presenting symptoms of fever, cough, shortness of breath, chest pain, or nausea and vomiting were more likely to require admission. The median duration from initial positive test to RT-PCR viral clearance was 26 days. Disease progression, time to viral clearance and duration of symptoms did not vary significantly by trimester of infection. CONCLUSIONS: Management of the majority of pregnant women with symptomatic COVID-19 illness can be accomplished in the outpatient setting with intensive and protocol-driven monitoring for symptom progression.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/nnvmnnoh_hasAnnotation_C0008031> <https://research.tib.eu/covid-19/entity/nnvmnnoh_hasAnnotation_C0010200> <https://research.tib.eu/covid-19/entity/nnvmnnoh_hasAnnotation_C0013404> <https://research.tib.eu/covid-19/entity/nnvmnnoh_hasAnnotation_C0015967> <https://research.tib.eu/covid-19/entity/nnvmnnoh_hasAnnotation_C0027497> <https://research.tib.eu/covid-19/entity/nnvmnnoh_hasAnnotation_C0042963> <https://research.tib.eu/covid-19/entity/nnvmnnoh_hasAnnotation_C0242656> <https://research.tib.eu/covid-19/entity/nnvmnnoh_hasAnnotation_C1457887>
?:creator	<https://research.tib.eu/covid-19/entity/Soffer%2C_M_D%3B_Shook%2C_L_L%3B_James%2C_K%3B_Sawyer%2C_M_R%3B_Ciaranello%2C_A%3B_Mahrouk%2C_R%3B_Bernstein%2C_S_N%3B_Boatin%2C_A_A%3B_Edlow%2C_A_G%3B_York-Best%2C_C%3B_Kaimal%2C_A_J%3B_Goldfarb%2C_I_T>
?:doi	<https://research.tib.eu/covid-19/entity/10.1093/ofid/ofaa524>
?:doi	10.1093/ofid/ofaa524
?:journal	Open_Forum_Infect_Dis
?:license	cc-by-nc-nd
?:pdf_json_files	document_parses/pdf_json/1c9c07d9a03f93c71a1b81398ae917d48de237cb.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7665663>
?:pmid	<https://research.tib.eu/covid-19/entity/33241071.0>
?:pmid	33241071.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/1c9c07d9a03f93c71a1b81398ae917d48de237cb>
?:source	Medline; PMC
?:title	Protocol-driven intensive outpatient management of pregnant patients with symptomatic COVID-19
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-27

Property

Value

?:abstract

BACKGROUND: Reports of SARS-CoV2 infection have focused on pregnant women hospitalized due to moderate to severe COVID-19 disease or asymptomatic women diagnosed through universal screening at the time of obstetric admission. Many pregnant women who have symptomatic SARS-CoV2 infection may not meet criteria for hospitalization; however, whether and how these women can be managed safely in outpatient setting is not well described. OBJECTIVE: We sought to describe the time to symptom and viral clearance and to identify predictors of hospitalization in order to better understand the safety of monitoring pregnant patients with symptomatic COVID-19 in the outpatient setting. STUDY DESIGN: We performed a retrospective cohort study of pregnant patients with symptomatic, confirmed COVID-19 illness at a large academic medical center. Patients had systematic telehealth follow up by a clinician team to assess for symptoms, provide virtual prenatal care, and arrange in-person visits when appropriate in a dedicated outpatient center. Data was collected via chart abstraction. RESULTS: Of 180 pregnant patients presenting with symptoms and undergoing RT-PCR testing, 67 patients with confirmed COVID-19 infection were identified during the study period. Nineteen (28%) required acute care given worsening of COVID-19 symptoms, and 95% of these were directed to this acute care setting due to symptom severity telehealth evaluation. Nine women (13%) were admitted to the hospital given worsening symptoms, 3 required ICU care, 2 required ventilatory support, and 2 required delivery. Women with the presenting symptoms of fever, cough, shortness of breath, chest pain, or nausea and vomiting were more likely to require admission. The median duration from initial positive test to RT-PCR viral clearance was 26 days. Disease progression, time to viral clearance and duration of symptoms did not vary significantly by trimester of infection. CONCLUSIONS: Management of the majority of pregnant women with symptomatic COVID-19 illness can be accomplished in the outpatient setting with intensive and protocol-driven monitoring for symptom progression.

is ?:annotates of